| Soluble endoglin contributes to the pathogenesis of preeclampsia S Venkatesha, M Toporsian, C Lam, J Hanai, T Mammoto, YM Kim, ... Nature medicine 12 (6), 642-649, 2006 | 2469 | 2006 |
| BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury M Zeisberg, J Hanai, H Sugimoto, T Mammoto, D Charytan, F Strutz, ... Nature medicine 9 (7), 964-968, 2003 | 1796 | 2003 |
| Smad6 inhibits signalling by the TGF-β superfamily T Imamura, M Takase, A Nishihara, E Oeda, J Hanai, M Kawabata, ... Nature 389 (6651), 622-626, 1997 | 1431 | 1997 |
| TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4 A Nakao, T Imamura, S Souchelnytskyi, M Kawabata, A Ishisaki, E Oeda, ... The EMBO journal, 1997 | 1356 | 1997 |
| Interaction and functional cooperation of PEBP2/CBF with Smads: synergistic induction of the immunoglobulin germline Cα promoter J Hanai, LF Chen, T Kanno, N Ohtani-Fujita, WY Kim, WH Guo, T Imamura, ... Journal of Biological Chemistry 274 (44), 31577-31582, 1999 | 563 | 1999 |
| c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads S Akiyoshi, H Inoue, J Hanai, K Kusanagi, N Nemoto, K Miyazono, ... Journal of Biological Chemistry 274 (49), 35269-35277, 1999 | 528 | 1999 |
| Targeting lactate dehydrogenase-a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells H Xie, J Hanai, JG Ren, L Kats, K Burgess, P Bhargava, S Signoretti, ... Cell metabolism 19 (5), 795-809, 2014 | 517 | 2014 |
| A RUNX2/PEBP2αA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia YW Zhang, N Yasui, K Ito, G Huang, M Fujii, J Hanai, H Nogami, T Ochi, ... Proceedings of the National Academy of Sciences 97 (19), 10549-10554, 2000 | 425 | 2000 |
| Parathyroid hormone directs bone marrow mesenchymal cell fate Y Fan, J Hanai, PT Le, R Bi, D Maridas, V DeMambro, CA Figueroa, S Kir, ... Cell metabolism 25 (3), 661-672, 2017 | 393 | 2017 |
| Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1 J Hanai, M Dhanabal, SA Karumanchi, C Albanese, M Waterman, B Chan, ... Journal of biological chemistry 277 (19), 16464-16469, 2002 | 391 | 2002 |
| Cell surface glypicans are low-affinity endostatin receptors SA Karumanchi, V Jha, R Ramchandran, A Karihaloo, L Tsiokas, B Chan, ... Molecular cell 7 (4), 811-822, 2001 | 379 | 2001 |
| The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity J Hanai, P Cao, P Tanksale, S Imamura, E Koshimizu, J Zhao, S Kishi, ... The Journal of clinical investigation 117 (12), 3940-3951, 2007 | 373 | 2007 |
| Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA S Miura, T Takeshita, H Asao, Y Kimura, K Murata, Y Sasaki, JI Hanai, ... Molecular and cellular biology 20 (24), 9346-9355, 2000 | 238 | 2000 |
| Endostatin is a potential inhibitor of Wnt signaling J Hanai, J Gloy, SA Karumanchi, S Kale, J Tang, G Hu, B Chan, ... The Journal of cell biology 158 (3), 529-539, 2002 | 225 | 2002 |
| Role of p300, a transcriptional coactivator, in signalling of TGF‐β A Nishihara, J Hanai, N Okamoto, J Yanagisawa, S Kato, K Miyazono, ... Genes to Cells 3 (9), 613-623, 1998 | 184 | 1998 |
| Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen‐activated protein kinase (MAPK) and phosphatidylinositol‐3 … J Hanai, N Doro, AT Sasaki, S Kobayashi, LC Cantley, P Seth, ... Journal of cellular physiology 227 (4), 1709-1720, 2012 | 182 | 2012 |
| Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells J Hanai, T Mammoto, P Seth, K Mori, SA Karumanchi, J Barasch, ... Journal of Biological Chemistry 280 (14), 13641-13647, 2005 | 161 | 2005 |
| Magic roundabout, a tumor endothelial marker: expression and signaling P Seth, Y Lin, J Hanai, V Shivalingappa, MP Duyao, VP Sukhatme Biochemical and biophysical research communications 332 (2), 533-541, 2005 | 152 | 2005 |
| Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect P Cao, J Hanai, P Tanksale, S Imamura, VP Sukhatme, SH Lecker The FASEB Journal 23 (9), 2844, 2009 | 140 | 2009 |
| Citrate suppresses tumor growth in multiple models through inhibition of glycolysis, the tricarboxylic acid cycle and the IGF-1R pathway JG Ren, P Seth, H Ye, K Guo, J Hanai, Z Husain, VP Sukhatme Scientific reports 7 (1), 4537, 2017 | 134 | 2017 |
Vikas P. SukhatmeEmory School of Medicineemory.edu의 이메일 확인됨